Serological responses to the first four doses of SARS-CoV-2 vaccine in patients with inflammatory bowel disease

Detalles Bibliográficos
Autores principales: Quan, Joshua, Ma, Christopher, Panaccione, Remo, Hracs, Lindsay, Sharifi, Nastaran, Herauf, Michelle, Markovinović, Ante, Coward, Stephanie, Windsor, Joseph W, Caplan, Léa, Ingram, Richard J M, Charlton, Carmen, Kanji, Jamil N, Tipples, Graham, Holodinsky, Jessalyn K, Bernstein, Charles N, Mahoney, Douglas J, Bernatsky, Sasha, Benchimol, Eric I, Kaplan, Gilaad G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597523/
https://www.ncbi.nlm.nih.gov/pubmed/36306801
http://dx.doi.org/10.1016/S2468-1253(22)00340-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597523/
https://www.ncbi.nlm.nih.gov/pubmed/36306801
http://dx.doi.org/10.1016/S2468-1253(22)00340-5

Ejemplares similares